AI can drive cars and play chess better than the masters, but can it really aid medicinal chemistry?
Using artificial intelligence to predict outcomes of organic chemistry at IBM Research – Zurich
On the virtues of automated quantitative structure–activity relationship: the new kid on the block
Combining human thinking with computer tactics: the future of medicinal chemistry?
Computational chemical biology: the intersection between chemical biology and computational chemistry
Perspective: the benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions
New computational approach identifies not so novel drugs to tackle ovarian cancer
Lead to Hit, rather than Hit to Lead: why medicinal chemists at GlaxoSmithKline are working backwards
In silico functional elucidation of uncharacterized proteins of Chlamydia abortus strain LLG